Developer of a biotechnology platform intended to create a novel class of therapeutics for the treatment of cancer and infectious disease. The company's platform specializes in disease-specific target identification, and validation as well as immunotherapeutic drug development for cancer, infectious, and autoimmune diseases and allergy, enabling healthcare practitioners to avail breakthrough therapeutic target discovery and validation with further drug development applications.